about
Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected IndividualsPredicting HLA alleles from high-resolution SNP data in three Southeast Asian populations.Missing data imputation and haplotype phase inference for genome-wide association studies.Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.HIV subtype influences HLA-B*07:02-associated HIV disease outcome.Early immune adaptation in HIV-1 revealed by population-level approaches.Ultra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencingMeasuring ambiguity in HLA typing methods.Co-operative additive effects between HLA alleles in control of HIV-1HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck.Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individualsKiller-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reactionGenotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.A novel single cDNA amplicon pyrosequencing method for high-throughput, cost-effective sequence-based HLA class I genotyping.Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemictat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.Impact of pre-adapted HIV transmission.Rare HLA drive additional HIV evolution compared to more frequent alleles.Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine.Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.Long read nanopore sequencing for detection of HLA and CYP2D6 variants and haplotypes.Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis.Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments.Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.Novel HLA class I associations with HIV-1 control in a unique genetically admixed population.
P2860
Q28552777-2CDA050C-7119-4D56-991B-A940B4D5DBB9Q30793085-E2129CC7-0514-4B79-9214-0DEA9A5AFE79Q33375386-ABF1B7FA-0709-41CE-AB66-559AC6FEFE4FQ33385995-FECD7921-05B7-48F6-9D0E-B6B554316155Q33566546-456F1322-C856-432F-AE78-4EB8686A5898Q34308788-58189C32-5F1E-440B-BC99-4D00DECCC9ADQ34367478-AEC5A87C-97AA-456F-820A-6E79C310442EQ34405338-6198735C-98E6-4ECA-8D21-83D34C1B4838Q34456570-B494B149-4DE6-46D9-9D6B-91EF1803534BQ34906292-B4539BA2-2CDF-426B-A69E-34550C3C7C6CQ35077768-17C2ADA7-DE81-4314-A997-91BA6FAC656CQ35148027-9DC8C9CF-0415-4A4E-8200-E40A7845CB15Q35156765-539F935E-4254-4067-9ADB-E4A5F628EF7CQ35321693-89388BEE-04EE-43E8-9F6B-44E3FD570EEDQ36397593-24D08C21-556A-4BB4-BF2D-30EDD1504F68Q36414578-F07A739D-3EA5-4980-B8DE-F176C06055E9Q36414604-0BB44972-CBD5-41B4-A722-330065A5C1C2Q36481449-3244DFD3-31D7-4B38-A109-0C2C428731EBQ36827396-71824E0F-E9BC-404F-8511-D185A574780FQ36984267-297C5527-3B7E-49D3-B04D-A175EA7DB8C4Q37219577-4CB3BD3B-F44A-4A73-A862-FA33B78BB7DAQ37407229-043FB990-2E0C-4853-967E-21DD27242EBBQ37641415-7D155033-8410-4DFF-B86A-603E70956014Q37714013-73F4C0FA-7981-4CF0-823E-14F06BE83F78Q39219822-5B010007-1E2E-48D7-A011-D030ED7790ECQ39496541-C222E327-BE24-4466-B531-244158E9C6D4Q40304304-11699B2E-8C89-4DDE-8C24-FF21837B110BQ40501405-CCC4374A-FD15-4211-B09A-B91015D7C12AQ40634933-1606E791-6D31-4962-ACC2-F559548FD833Q40653419-F589024F-7DFF-4877-AB25-DB14AA65A2C7Q46228816-930DCB8F-DE48-4D07-BE40-2B387256FD55Q47593460-9AB83FBB-EFBC-47AA-88EA-D1643CBB4E93Q51579145-54BF2725-EF01-453A-B925-33BA9BCC6D46Q54233740-08119359-2B6D-4002-BAC0-A0B48CB5BC42
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Statistical resolution of ambiguous HLA typing data
@ast
Statistical resolution of ambiguous HLA typing data
@en
type
label
Statistical resolution of ambiguous HLA typing data
@ast
Statistical resolution of ambiguous HLA typing data
@en
prefLabel
Statistical resolution of ambiguous HLA typing data
@ast
Statistical resolution of ambiguous HLA typing data
@en
P2093
P2860
P50
P1476
Statistical resolution of ambiguous HLA typing data
@en
P2093
Carl Kadie
Gao Xiaojiang
Jennifer Listgarten
P2860
P304
P356
10.1371/JOURNAL.PCBI.1000016
P577
2008-02-29T00:00:00Z